Fundraising Fox

Passage Bio

NASDAQ: PASG

Philadelphia, US · Founded 2017 · Delaware corporation · 1 known investors

passagebio.com ↗

Passage Bio is a company focused on developing treatments for central nervous system (CNS) diseases, with an emphasis on neurodegenerative conditions. It positions patients living with or born with CNS diseases at the center of its work.

BiotechHealthtech

Founders & leadership

CG
Carl GordonDirector
TY
Tadataka YamadaExecutive Officer, Director, Promoter
SI
Saqib IslamDirector
TS
Thomas Street Address 1 WoiwodeDirector
SS
Stephen SquintoExecutive Officer, Director
PH
Patrick HeronDirector

Investors · 1

Frazier Life SciencesPalo Altovia Patrick Heron · board

Reported raises · per SEC filings

Form D private placements
▶$110MraisedSep 2019 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Patrick HeronDirector
  • Carl GordonDirector
  • Tadataka YamadaExecutive Officer, Director, Promoter
  • Saqib IslamDirector
  • Thomas Street Address 1 WoiwodeDirector
  • Stephen SquintoExecutive Officer, Director
Offering amount
$110M
Amount sold
$110M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b, 3C, 3C.1
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.